PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA
Authors:
Open Access
- 16 October 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (37) , 40026-40035
Abstract
PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA PIK3CA mutation detection in metastatic biliary cancer using cell-free DNAKeywords
This publication has 41 references indexed in Scilit:
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Development of PI3K inhibitors: lessons learned from early clinical trialsNature Reviews Clinical Oncology, 2013
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature, 2012
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Best Supportive Care Compared With Chemotherapy for Unresectable Gall Bladder Cancer: A Randomized Controlled StudyJournal of Clinical Oncology, 2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancersLung Cancer, 2007
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004